(Dollars in Millions) | 2013 | 2012 | 2011 | ||||||||
U.S. | $ | 4,261 | 4,664 | 3,634 | |||||||
International | 11,210 | 9,111 | 8,727 | ||||||||
Earnings before taxes on income: | $ | 15,471 | 13,775 | 12,361 | |||||||
Tax rates: | |||||||||||
U.S. statutory rate | 35.0 | % | 35.0 | 35.0 | |||||||
International operations excluding Ireland | (10.6 | ) | (9.8 | ) | (14.0 | ) | |||||
Ireland and Puerto Rico operations | (9.0 | ) | (3.9 | ) | (1.8 | ) | |||||
Research and orphan drug tax credits | (0.8 | ) | — | (0.8 | ) | ||||||
U.S. state and local | 0.4 | 1.3 | 2.1 | ||||||||
U.S. manufacturing deduction | (0.8 | ) | (0.9 | ) | (0.8 | ) | |||||
U.S. tax on international income | 1.7 | 1.1 | (0.4 | ) | |||||||
U.S. tax benefit on asset write-offs | (5.1 | ) | — | — | |||||||
All other | (0.2 | ) | 0.9 | 2.5 | |||||||
Effective tax rate | 10.6 | % | 23.7 | 21.8 |